Citrate-Mediated Cell Differentiation and Long-Gene Transcription

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is an urgent need for methods to promote and maintain cell differentiation and gene expression, particularly in stem cells that are arrested in a quiescent state, to prevent conditions such as atherosclerosis, osteoporosis, sarcopenia, hair loss, and aging, which are associated with reduced cell differentiation and gene expression.

Innovation Solution

Administering citrate to a subject to increase cytosolic citrate levels, thereby increasing acetyl-CoA availability for histone acetylation, promoting cell differentiation, and maintaining cells in a differentiated state, and enhancing gene expression, especially of long genes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If stem cells are kept in a quiescent state, then cell proliferation is reduced, but cell differentiation is impaired

Engineering Contradiction:
Improvecell differentiationVSAvoidcell proliferation
Core Design Contradiction:
Stability of the object's compositionVSProductivity

Solution Approach 1:

The patent applies parameter changes by introducing citrate, which alters the metabolic state of stem cells. Citrate enters the cell and is converted to acetyl-CoA, changing the biochemical parameters of the cell to promote differentiation while maintaining quiescence. This resolves the contradiction by modifying cellular metabolism rather than directly affecting cell cycle progression.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If gene expression is reduced, then energy consumption is lowered, but cell functionality is impaired

Engineering Contradiction:
Improvecell functionalityVSAvoidenergy consumption
Core Design Contradiction:
ReliabilityVSUse of energy by moving object

Solution Approach 1:

The patent uses parameter changes by providing citrate, which modifies the biochemical environment to enhance gene expression. Citrate serves as a substrate for histone acetylation, changing the chromatin structure and allowing more genes to be expressed without requiring proportional increases in energy consumption, thus resolving the contradiction between functionality and energy use.

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If differentiated cells undergo dedifferentiation, then cell plasticity is increased, but cell specialization is lost

Engineering Contradiction:
Improvecell plasticityVSAvoidcell specialization
Core Design Contradiction:
Adaptability or versatilityVSStability of the object's composition

Solution Approach 1:

The patent introduces citrate as an intermediary substance that maintains cell specialization by providing acetyl-CoA for histone acetylation. This intermediary mechanism prevents dedifferentiation by sustaining the biochemical conditions necessary for maintaining differentiated gene expression patterns, thus resolving the contradiction between plasticity and specialization.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Citrate administration promotes stem cell differentiation, reduces cell dedifferentiation, maintains cellular function, and increases gene expression, leading to improved muscle mass, hair growth, wound healing, and prevention of conditions like osteoporosis and aging.

Implementation Method 1

Administering citrate to a subject to increase cytosolic citrate levels, thereby increasing acetyl-CoA availability for histone acetylation

Methodology Applied
Scientific EffectCitrate metabolism to acetyl-CoA: Chemical Bonding

Implementation Method 2

increasing acetyl-CoA availability for histone acetylation, promoting cell differentiation

Methodology Applied
Scientific EffectHistone acetylation: Chemical Bonding

Implementation Method 3

promotes transcription of genes, particularly genes>10 kb in length which would otherwise be susceptible to stalling and/or premature termination of the RNA Polymerase II complex

Methodology Applied
Scientific EffectTranscription: Chemical Bonding

Data Source

PatentUS20250248957A1Cell differentiation
Publication Date: 2025.08.07 JOHN HEMMING TRADING LTD
  • US20250248957A1 patent drawing
  • US20250248957A1 patent drawing
  • US20250248957A1 patent drawing

AI summary

The invention relates to methods for promoting and maintaining cell differentiation and gene expression in a subject, and ensuring that longer genes are able to function, the method comprising administering citrate to a subject. The invention also relates to compositions for use in said methods.